A distinguished panel of experts in hematologic malignancies have an engaging discussion on the current and potential future treatment approaches for MCL.
EP. 2: Patient Profile 1: A 74-Year-Old Man Diagnosed With Mantle Cell LymphomaJanuary 17th 2023
A patient profile of a 74-year-old man diagnosed with mantle cell lymphoma who receives treatment with a non-covalent BTK inhibitor is presented by Alexey V. Danilov, MD, PhD.
EP. 5: SHINE Study: Ibrutinib Plus Bendamustine and Rituximab in Elderly Patients With MCLJanuary 31st 2023
A panel of experts in hematologic malignancies discuss the SHINE study, which looked at ibrutinib with bendamustine and rituximab in elderly patients with MCL.
EP. 7: Selecting the Appropriate BTKi in MCL and Potential Role of PirtobrutinibFebruary 7th 2023
A detailed look at how to select the appropriate BTK inhibitor to treat patients with MCL and the potential role of the non-covalent BTK inhibitor pirtobrutinib in MCL.